MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. Research & Clinical Trial Webinars,Webinars 8 years ago You may also like 52:15 Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences 10 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 29:09 PTC Therapeutics — EMFLAZA® Landscape in 2024 11 months ago Care Webinars,Webinars emflaza,ptc therapeutics 53:59 Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD 11 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:00:58 Navigating Steroid Choices: Understanding the Process, Pathways, and Policies 11 months ago Care Webinars,Webinars steroids 1:03:41 Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003 1 year ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 59:54 Overview of Topline Results from Phase 3 EMBARK Study 1 year ago Research & Clinical Trial Webinars,Webinars sarepta 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings 1 year ago Care Webinars,Webinars feature,insurance,medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 1 year ago Research & Clinical Trial Webinars,Webinars capricor «12345…25»Page 3 of 25
by: Parent Project Muscular Dystrophy
